Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

John Menzies plc buy krebskrebs

Start price
€1.23
05.10.20 / 50%
Target price
€2.00
04.11.21
Performance (%)
196.75%
End price
€3.65
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €3.65. The BUY prediction by krebskrebs for John Menzies plc saw massive gains of 196.75%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
John Menzies plc - - - -
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

Comments by krebskrebs for this prediction

In the thread John Menzies plc diskutieren
Prediction Buy
Perf. (%) 196.75%
Target price 2.000
Change
Ends at 04.11.21

Buy mit Kursziel 2,0

In the thread Trading John Menzies plc
Prediction Buy
Perf. (%) 196.75%
Target price 2.000
Change
Ends at 04.11.21

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten